Product Image

L-Carnitine Fumarate With Biosint Carnitines 855 mg

Doctor's Best
4.6
★ ★ ★ ★ ★
(12499 ratings)
L-Carnitine 855 mg
Product Image
Score83
855 mg of compound of Biosint L-carnitine fumarate offers good value, but the focused formula has limited pathway coverage.
How scoring works
Quantity:60 Veggie Cap(s) • (60 servings)
Goals:
Cardiovascular Support

Score 83

855 mg of compound of Biosint L-carnitine fumarate offers good value, but the focused formula has limited pathway coverage.
How scoring works
$19.99($0.33 per serving)
Vitacost
$ 21.97
Amazon
$ 19.99
iHerb
$ 19.99
Report prices

Analysis

Biosint sourcing is a meaningful advantage because it makes the raw material more traceable than generic fumarate. The 855 mg of compound serving is presented in a vegetable capsule format for routine use.

The 855 mg figure represents the full fumarate compound and does not directly state the estimated active carnitine yield. Benefits are most likely when carnitine support is relevant rather than as a universal performance or heart-health effect.

The formula stays focused on fatty-acid transport and cellular energy rather than broad cardiovascular or performance coverage. Good value and 60 servings shape the practical appeal.

Who is it for
  • Adults seeking a simple carnitine supplement
  • Users seeking maintenance-level cellular-energy support
Best for
  • Focused fatty-acid transport support
  • Value-conscious carnitine use

Pros

  • Provides 855 mg of compound per labeled serving
  • Clearly identifies Biosint L-carnitine fumarate
  • Vegetable capsule format
  • Good value

Cons

  • No independent purity or testing standard is disclosed
  • Elemental L-carnitine yield is not stated directly
  • Supports a narrow metabolic pathway rather than broad cardiovascular coverage

Nutrient quality

90 Highest impact

The branded Biosint fumarate source adds credible purity assurance and fits cardiovascular energy support. The label gives compound weight rather than a directly stated elemental yield.

Ingredient transparency

80 High impact

Active complex amounts and serving details are stated clearly. The label gives compound weight rather than a directly stated elemental yield.

Customer satisfaction

72 High impact

The supplied average rating is strong, and a very large response volume makes the average rating more stable. No comment-level feedback is supplied to judge recurring complaints or purpose-specific experiences.

Value for money

88 Highest impact

Branded sourcing and reasonable serving cost support good value. Formula focus and disclosure determine whether that value holds up in practice.

Report analysis

Goals

Cardiovascular Support
Impact
High effect
B Goal FitC+ Strength of SupportD- CoverageA Formula Quality
L-Carnitine · 855 mg

L-carnitine fumarate supports fatty-acid transport into mitochondria, a relevant energy pathway for heart muscle. Human cardiovascular evidence is useful in selected clinical contexts but less dependable for routine prevention.

The Biosint source supports purity, yet the 855 mg compound weight yields only about 496 mg of elemental carnitine. Missing elemental-yield disclosure limits confidence that the amount reaches a full maintenance target.

Study evidence
L-Carnitine Supportive 73 studies

Ingredients

IngredientAmount per serving
L-Carnitine Fumarate
855 mg
Gluten Free Adults 18–50 Vegan Vegetarian
Report overview
L-Carnitine · 855 mg OverallScore77
A+ Active Ingredient Quality & BioavailabilityD+ Dose, Safety & Label TransparencyB+ Value

L-carnitine fumarate is well suited to cardiovascular energy support and the Biosint source adds strong purity assurance. The label lists compound weight rather than elemental yield, leaving an estimated carnitine amount just below the standard maintenance range. Its low serving cost provides good value after adjusting for the fumarate fraction.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. The Effects of L-Carnitine on Echocardiographic Changes in Patients With β-Thalassemia Major and Intermedia.
    Shahidi M; Hashemi SR; Fattahi N; Roshani D; Vahedi S; Sharifi P; Moradveisi B · Journal of pediatric hematology/oncology · 2020
    Randomized trial60 participantsCardiovascular Support forL-Carnitine
  2. The Effects of L-Carnitine Supplementation on Serum Lipids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Fathizadeh H; Milajerdi A; Reiner Ž; Kolahdooz F; Chamani M; Amirani E; Asemi Z · Current pharmaceutical design · 2020
    Meta-analysis67 studies pooledCardiovascular Support forL-Carnitine
  3. L-Carnitine supplementation reduces oxidized LDL cholesterol in patients with diabetes.
    Malaguarnera M; Vacante M; Avitabile T; Malaguarnera M; Cammalleri L; Motta M · The American journal of clinical nutrition · 2009
    Randomized trial81 participantsCardiovascular Support forL-Carnitine
  4. L-Carnitine's Effect on the Biomarkers of Metabolic Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Choi M; Park S; Lee M · Nutrients · 2021
    Meta-analysis9 studies pooledCardiovascular Support forL-Carnitine
  5. The Effects of L-Carnitine Supplementation on Weight Loss, Glycemic Control, and Cardiovascular Risk Factors in Patients With Type 2 Diabetes: A Systematic Review and Dose-response Meta-Analysis of Randomized Controlled Trials.
    Mirrafiei A; Jayedi A; Shab-Bidar S · Clinical therapeutics · 2024
    Meta-analysis2,041 participants21 studies pooledCardiovascular Support forL-Carnitine
  6. Efficacy and tolerability of combined treatment with L-carnitine and simvastatin in lowering lipoprotein(a) serum levels in patients with type 2 diabetes mellitus.
    Solfrizzi V; Capurso C; Colacicco AM; D'Introno A; Fontana C; Capurso SA; Torres F; Gadaleta AM; Koverech A; Capurso A; Panza F · Atherosclerosis · 2007
    Randomized trial52 participantsCardiovascular Support forL-Carnitine